<DOC>
	<DOCNO>NCT01470287</DOCNO>
	<brief_summary>This study evaluate immunogenicity , safety tolerability fully liquid pentavalent vaccine ( DTwP-Hib-HepB Vaccine ) infants 6-8 week age .</brief_summary>
	<brief_title>Immunogenicity , Safety Tolerability Fully Liquid Pentavalent ( DTwP-Hib-Hep B ) Vaccine Infants 6-8 Weeks Age</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female subject ≥ 42 day ≤ 64 day age . 2 . Written inform consent obtain either parents/ legal guardian nature study explain accord local regulatory requirement 1 . Subjects whose parent legal guardian unwilling unable give write informed consent participate study . 2 . History previous immunization vaccine contain 5 antigen component investigational vaccine . 3 . History anaphylactic shock ( immediate hypersensitivity reaction ) , urticaria allergic reaction previous vaccination know hypersensitivity vaccine component . 4 . Administration parenteral immunoglobulin preparation and/or blood product since birth .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>64 Days</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Infants ,</keyword>
	<keyword>Immunogenicity ,</keyword>
	<keyword>Safety</keyword>
</DOC>